Global Neurosurgery Market – Industry Trends, Technology and Forecast to 2030

Table of Contents

Table of Contents:
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL NEUROSURGERY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 IBI TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 IBI MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 INDUSTRIAL INSIGHTS:
4.4 CONCLUSION
5 REGULATIONS OF THE GLOBAL NEUROSURGERY MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENT IN NEUROSURGERY
6.1.2 RISING PREVALENCE OF NEUROLOGICAL CONDITIONS
6.1.3 DEVELOPMENTS IN SURGICAL EQUIPMENT
6.2 RESTRAINTS
6.2.1 THE HIGH COST ASSOCIATED WITH NEUROSURGERIES AND EQUIPMENT
6.2.2 UNFAVOURABLE REIMBURSEMENT POLICIES
6.3 OPPORTUNITIES
6.3.1 RISING AWARENESS ABOUT NEUROLOGICAL DISORDERS
6.3.2 INCREASING NUMBER OF KEY PLAYERS IN MARKET
6.3.3 ADVANCE PRODUCT DEVELOPMENT AND LAUNCHES IN RECENT YEARS
6.4 CHALLENGES
6.4.1 ALTERNATIVE TREATMENTS FOR NEUROLOGICAL DISEASE
6.4.2 STRINGENT REGULATIONS FOR APPROVAL OF MEDICAL DEVICES
7 GLOBAL NEUROSURGERY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 NEUROSURGERY DEVICES
7.2.1 NEUROMODULATION DEVICES
7.2.1.1 INTERNAL NEUROMODULATION DEVICES
7.2.1.1.1 SPINAL CORD STIMULATION DEVICES
7.2.1.1.1.1 RECHARGEABLE
7.2.1.1.1.2 NON- RECHARGEABLE
7.2.1.1.2 DEEP BRAIN STIMULATION DEVICES
7.2.1.1.2.1 SINGLE-CHANNEL DEEP BRAIN STIMULATION
7.2.1.1.2.2 DUAL-CHANNEL DEEP BRAIN STIMULATION
7.2.1.1.3 SACRAL NERVE STIMULATION DEVICES
7.2.1.1.3.1 IMPLANTABLE
7.2.1.1.3.2 EXTERNAL
7.2.1.1.4 VAGUS NERVE STIMULATION DEVICES
7.2.1.1.4.1 INVASIVE
7.2.1.1.4.2 EXTERNAL
7.2.1.1.5 GASTRIC ELECTRICAL STIMULATION DEVICES
7.2.1.1.5.1 LOW FREQUENCY GASTRIC ELECTRICAL STIMULATORS
7.2.1.1.5.2 HIGH FREQUENCY GASTRIC ELECTRICAL STIMULATORS
7.2.1.1.6 EXTERNAL NEUROMODULATION DEVICES
7.2.1.1.6.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
7.2.1.1.6.2 TRANSCRANIAL MAGNETIC STIMULATION (TMS)
7.2.1.1.6.3 OTHERS
7.2.2 NEURO-INTERVENTIONAL DEVICES
7.2.2.1 EMBOLIZATION COILS
7.2.2.1.1 DETACHABLE
7.2.2.1.2 PUSHABLE
7.2.2.2 CAROTID STENTS
7.2.2.3 INTRACRANIAL STENTS
7.2.2.4 NEUROVASCULAR THROMBECTOMY
7.2.2.4.1 COIL RETRIEVERS
7.2.2.4.2 ASPIRATION DEVICES
7.2.2.4.3 STENT RETRIEVERS
7.2.2.5 INTRASSACULAR DEVICES
7.2.2.6 BALLOONS
7.2.2.7 OTHERS
7.2.3 NEUROSURGERY SURGICAL POWER TOOLS
7.2.3.1 DRILL
7.2.3.1.1 PNEUMATIC NEUROSURGICAL DRILLS
7.2.3.1.2 ELECTRICAL NEUROSURGICAL DRILLS
7.2.3.2 SAW
7.2.3.3 OTHERS
7.2.4 NEUROSURGICAL NAVIGATION SYSTEMS
7.2.5 CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES
7.2.5.1 CSF SHUNTS
7.2.5.2 EXTERNAL DRAINAGE SYSTEM
7.2.6 NEUROSURGICAL MICROSCOPE
7.2.7 CRANIAL STABILIZATION
7.2.8 NEUROENDOSCOPY DEVICES
7.2.9 INTRA OPERATIVE IMAGING
7.2.10 BRAIN MONITORING
7.2.11 NEUROSURGICAL EVACUATION DEVICES
7.2.12 STEREOTACTIC SYSTEMS
7.2.13 ULTRASONIC ASPIRATOR
7.2.14 BIPOLAR EQUIPMENT
7.3 NEUROSURGERY SOFTWARE
7.3.1 IMAGING NEUROSURGERY SOFTWARE
7.3.2 PRE-OPERATION PLANNING NEUROSURGERY SOFTWARE
7.3.3 OTHERS
7.4 CONSUMABLES
8 GLOBAL NEUROSURGERY MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 PEDIATRIC
8.3 ADULT
8.4 GERIATRIC
9 GLOBAL NEUROSURGERY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BRAIN TUMORS
9.3 TRAUMA SURGERY
9.4 SPINE SURGERY
9.5 PARKINSON’S DISEASE AND TREMORS
9.6 PERIPHERAL NERVE SURGERY
9.7 EPILEPSY
9.8 FUNCTIONAL NEUROSURGERY
9.9 CAROTID ARTERY BLOCKAGE/STENOSIS
9.1 INTRAOPERATIVE ANGIOGRAPHY
9.11 CEREBROVASCULAR SURGERY
9.12 ANEURYSMS
9.13 PITUITARY TUMORS
9.14 RADIOSURGERY
9.15 STEREOTACTIC NEUROSURGERY
9.16 CORTICAL MAPPING
9.17 ARTERIOVENOUS MALFUNCTION (AVM)
9.18 SKULL BASE SURGERY
9.19 TRIGEMINAL NEURALGIA
9.2 OTHERS
10 GLOBAL NEUROSURGERY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 ACUTE CARE HOSPITALS
10.2.2 LONG-TERM CARE HOSPITALS
10.2.3 NURSING FACILITIES
10.2.4 REHABILITATION CENTERS
10.3 RESEARCH CENTERS
10.4 NEUROSURGERY CENTERS
10.5 AMBULATORY SURGICAL CENTERS (ASCS)
10.6 OTHERS
11 GLOBAL NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 GLOBAL NEUROSURGERY MARKET, BY REGION
12.1 OVERVIEW
12.2 NORTH AMERICA
12.2.1 U.S.
12.2.2 CANADA
12.2.3 MEXICO
12.3 EUROPE
12.3.1 GERMANY
12.3.2 FRANCE
12.3.3 U.K.
12.3.4 ITALY
12.3.5 RUSSIA
12.3.6 SPAIN
12.3.7 TURKEY
12.3.8 NETHERLANDS
12.3.9 SWITZERLAND
12.3.10 BELGIUM
12.3.11 REST OF EUROPE
12.4 ASIA-PACIFIC
12.4.1 CHINA
12.4.2 JAPAN
12.4.3 SOUTH KOREA
12.4.4 INDIA
12.4.5 AUSTRALIA
12.4.6 SINGAPORE
12.4.7 THAILAND
12.4.8 MALAYSIA
12.4.9 INDONESIA
12.4.10 PHILIPPINES
12.4.11 REST OF ASIA-PACIFIC
12.5 SOUTH AMERICA
12.5.1 BRAZIL
12.5.2 ARGENTINA
12.5.3 REST OF SOUTH AMERICA
12.6 MIDDLE EAST AND AFRICA
12.6.1 SOUTH AFRICA
12.6.2 SAUDI ARABIA
12.6.3 UAE
12.6.4 EGYPT
12.6.5 ISRAEL
12.6.6 REST OF MIDDLE EAST AND AFRICA
13 GLOBAL NEUROSURGERY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 MEDTRONIC
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 STRYKER
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ABBOTT
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 INTEGRA LIFESCIENCES (2021)
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ADEOR MEDICAL AG
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 ADVANTIS MEDICAL IMAGING
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 ALEVA NEUROTHERAPEUTICS
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 ANT NEURO
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 B. BRAUN SE
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 BIOINDUCTION
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 BRAINLAB AG
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 ELEKTA
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 EMS HANDELS GESELLSCHAFT MBH
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 INOMED MEDIZINTECHNIK GMBH
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 KARL STORZ SE & CO. KG
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 LEICA MICROSYSTEMS
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 LIVANOVA PLC
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 NEVRO CORP.
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 OPTOFINE INSTRUMENTS PVT. LTD.
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 PENUMBRA, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 RENISHAW PLC.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PORTFOLIO
15.22.4 RECENT DEVELOPMENT
15.23 SYNAPSE BIOMEDICAL INC.
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENT
15.24 TERUMO MEDICAL CORPORATION
15.24.1 COMPANY SNAPSHOT
15.24.2 REVENUE ANALYSIS
15.24.3 PRODUCT PORTFOLIO
15.24.4 RECENT DEVELOPMENTS
15.25 MACHIDA ENDOSCOPE CO. LTD.
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENTS
15.26 NALU MEDICAL, INC.
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENT
15.27 WALLABY MEDICAL
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS